Harvard Bioscience (HBIO) Work In Process (2011 - 2026)
Harvard Bioscience (HBIO) posted quarterly Work In Process of $3.4 million for Q1 2026, up 11.4% year-over-year from $3.0 million in Q1 2025, and up 3.03% quarter-over-quarter from $3.3 million in Q4 2025.
Harvard Bioscience (HBIO) Work In Process (2011 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Work In Process for 16 consecutive years, with $3.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Work In Process rose 11.4% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 11.4% YoY), while the FY2025 annual figure was $3.3 million, up 18.45% from the prior year.
- Work In Process improved to $3.4 million in Q1 2026 per HBIO's latest filing, from $3.3 million in the prior quarter.
- Across five years, Work In Process topped out at $4.6 million in Q3 2023 and bottomed at $1.6 million in Q2 2025.
- Historically, Work In Process has averaged $3.4 million across 5 years, with a median of $3.4 million in 2022.
- Annual changes were most pronounced in 2023 — Work In Process advanced 20.7% — and 2025, when it tumbled 52.79%.
- Harvard Bioscience's Work In Process stood at $3.8 million in 2022, then gained by 10.91% to $4.2 million in 2023, then slumped by 34.24% to $2.8 million in 2024, then rose by 18.45% to $3.3 million in 2025, then rose by 3.03% to $3.4 million in 2026.
- Business Quant data shows HBIO's Work In Process at $3.4 million in Q1 2026, $3.3 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.28 Mn |
| Mar 31, 2026 | 3.36 Mn |
| Dec 31, 2025 | 3.26 Mn |
| Sep 30, 2025 | 2.26 Mn |
| Jun 30, 2025 | 1.56 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 3.47 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 4.19 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 4.61 Mn |
| Mar 31, 2023 | 3.66 Mn |
| Dec 31, 2022 | 3.78 Mn |
| Sep 30, 2022 | 3.85 Mn |
| Jun 30, 2022 | 3.97 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | 3.51 Mn |